Document is current
Any future updates will be listed below
-
Authors
Goldberg, Gabriela
Coelho, Luisa
Mo, Guoya
Adang, Laura A.
Patne, Meenakshi
Chen, Zhoutao
Garcia-Bassets, Ivan
Mesci, Pinar https://orcid.org/0000-0003-3402-5671
Muotri, Alysson R. https://orcid.org/0000-0003-0867-2875
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD107788)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01NS105969, R01NS123642, U01 NS106845, U54TR002823, K23NS114113)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
California Institute for Regenerative Medicine (DISC1-08825)
National Science Foundation (DGE-1650112, DGE-2038238)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
- License Information
-
More Information
Article History
Received: 15 May 2023
Revised: 22 November 2023
Accepted: 27 November 2023
First Online: 21 December 2023
Competing interests
: ARM is the co-founder of and has an equity interest in TISMOO, a company dedicated to genetic analysis and human brain organogenesis, focusing on therapeutic applications customized to autism spectrum disorders and other neurological diseases. The terms of this arrangement have been reviewed and approved by the University of California San Diego, in accordance with its conflict-of-interest policies. GM, IG-B, and ZC declare competing financial interests in the form of stock ownership, patent application, or employment through Universal Sequencing Technologies Corporation. LAA is a consultant for Takeda, Biogen, and Orchard Therapeutics. Other authors declare no competing interests.
